Floré Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
Floré General Information
Description
Producer of custom probiotics intended for improving gut health. The company combines microbiome testing and different prebiotics and botanical ingredients to create a custom formulation, reduce constipation, relieve digestive issues, promote food tolerance, support GI motility, support digestive quality of life, and support immunity, enabling individuals to address issues such as abdominal pain, constipation, bloating, small intestinal bacterial overgrowth, leaky gut, and other digestive issues.
Contact Information
Website
www.flore.comCorporate Office
- 51 West Jackson Street
- Suite 105
- Joliet, IL 60432
- United States
Corporate Office
- 51 West Jackson Street
- Suite 105
- Joliet, IL 60432
- United States
Floré Timeline
Floré Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC | 15-Aug-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 19-Nov-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 23-Dec-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 23-Nov-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 09-Aug-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A) | 29-Jun-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 26-Sep-2019 | Completed | Generating Revenue | |||
| 3. Seed Round | 03-Jan-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 06-Dec-2017 | $200K | $200K | Completed | Generating Revenue | |
| 1. Grant | 15-Dec-2016 | $5K | Completed | Generating Revenue |
Floré Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-6 | ||||||||
| Series B-5 | ||||||||
| Series B-4 | ||||||||
| Series B-3 | ||||||||
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series AA | ||||||||
| Series A-1A | ||||||||
| Seed-4A | 2,676,281 | $0.000100 | $0.47 | $0.47 | 1x | $0.36 | 4% | |
| Seed-3A | 1,302,375 | $0.000100 | $0.19 | $0.19 | 1x | $0.19 | 1.49% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Floré Comparisons
Industry
Financing
Details
Floré Competitors (7)
One of Floré’s 7 competitors is Evermind, a Formerly VC-backed company based in Lancaster, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Evermind | Formerly VC-backed | Lancaster, PA | ||||
| BIOHM Health | Venture Capital-Backed | Cleveland, OH | ||||
| Seed Health | Venture Capital-Backed | Los Angeles, CA | ||||
| Infinant Health | Venture Capital-Backed | Sacramento, CA | ||||
| Viome Life Sciences | Venture Capital-Backed | Bellevue, WA |
Floré Patents
Floré Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025222058-A1 | Microbiome impact in metabolic disorder | Pending | 18-Apr-2024 | ||
| CA-3223853-A1 | Systems and methods for identifying microbial signatures | Pending | 28-Jun-2021 | ||
| EP-4363603-A1 | Systems and methods for identifying microbial signatures | Inactive | 28-Jun-2021 | ||
| EP-4363603-A4 | Systems and methods for identifying microbial signatures | Inactive | 28-Jun-2021 | ||
| US-20240344152-A1 | Systems and methods for identifying microbial signatures | Pending | 28-Jun-2021 | C12Q1/689 |
Floré Signals
Floré Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ki Tua Fund | Corporate Venture Capital | Minority | ||
| dsm-firmenich Ventures | Corporate Venture Capital | Minority | ||
| Ferter | Venture Capital | Minority | ||
| IndieBio | Accelerator/Incubator | Minority | ||
| Plug and Play | Accelerator/Incubator | Minority |
Floré FAQs
-
When was Floré founded?
Floré was founded in 2016.
-
Where is Floré headquartered?
Floré is headquartered in Joliet, IL.
-
What is the size of Floré?
Floré has 9 total employees.
-
What industry is Floré in?
Floré’s primary industry is Other Consumer Non-Durables.
-
Is Floré a private or public company?
Floré is a Private company.
-
What is Floré’s current revenue?
The current revenue for Floré is .
-
How much funding has Floré raised over time?
Floré has raised $27.1M.
-
Who are Floré’s investors?
Ki Tua Fund, dsm-firmenich Ventures, Ferter, IndieBio, and Plug and Play are 5 of 14 investors who have invested in Floré.
-
Who are Floré’s competitors?
Evermind, BIOHM Health, Seed Health, Infinant Health, and Viome Life Sciences are some of the 7 competitors of Floré.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process